Ran out of edit time to add this to my last post. This is a continuation of the subject.
University of Oxford Announces Positive News About COVID-19 Vaccination Trials
Behind the news:
Initial trials held to test the efficacy of a
COVID-19 vaccine formulated by the University of Oxford are expected to return with positive results on the 20th of July, 2020. The conclusions of the trials are to be published in The Lancet – a general, peer-reviewed medical journal that is distributed on a weekly basis. The Monday publication is highly expected to carry news about the optimistic future of this fight against the novel coronavirus, with various reports of alleged double-protection and how it works having been published already.
This experimental vaccine was developed by the Jenner Institute, which is part of the Nuffield Department of Medicine at the University of Oxford. This formulation is backed by AstraZeneca PLC, a British-Swedish pharmaceutical company with a multinational presence in the biopharmaceutical industry. Ever since the announcement of potential positive results about the vaccine, the company’s share prices have increased considerably. AstraZeneca has not made any comments on it yet.
Continued at link.
Fingers crossed.
Info about Gavi
Bill and Melinda Gates Foundation pledges $1.6 billion to Gavi the Vaccine Alliance
SEATTLE, June 4, 2020 – The Bill & Melinda Gates Foundation today announced a five-year, US$1.6 billion commitment to Gavi, the Vaccine Alliance, to deliver lifesaving vaccines to the world’s poorest countries. The commitment was announced at the Global Vaccine Summit 2020, hosted by Prime Minister Boris Johnson of the United Kingdom.
Funding secured today for Gavi’s next strategic period will help the Alliance reach an additional 300 million children in the world’s most vulnerable communities and save up to eight million lives, bringing the total number of children immunized with Gavi support to more than one billion since its inception in 2000.
In addition to supporting the continuation of routine immunization services during the current COVID-19 crisis, Gavi will play a vital role in efforts to end the pandemic, leveraging its two decades of experience in vaccine delivery to deploy potential COVID-19 vaccines to low income countries when they become available.
“Not many people outside the global health sector have heard about Gavi, but over the past twenty years, it has transformed the way the world invests in and protects the health of its children,” said Melinda Gates, co-chair of the Bill & Melinda Gates Foundation. “If the current pandemic has reminded us of anything, it’s the importance of vaccinating against deadly diseases. The pledges that leaders are making today will help Gavi save even more lives.”
Continued at link.